Trade Report: Today, Nationwide Fund Advisors sells partial stakes of PerkinElmer Inc. (PKI)

Today, Nationwide Fund Advisors sells partial stakes of PerkinElmer Inc. (PKI)

Nationwide Fund Advisors decreased its stake in PerkinElmer Inc. (NYSE:PKI) by 3.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 30,579 shares of the company’s stock after selling 1,002 shares during the period. Nationwide Fund Advisors’ holdings in PerkinElmer were worth $1,603,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in PKI. CIBC Asset Management Inc raised its stake in PerkinElmer by 0.5% in the second quarter. CIBC Asset Management Inc now owns 10,175 shares of the company’s stock valued at $533,000 after buying an additional 46 shares during the period. Norinchukin Bank The raised its stake in PerkinElmer by 1.5% in the second quarter. Norinchukin Bank The now owns 5,718 shares of the company’s stock valued at $300,000 after buying an additional 83 shares during the period. Moody Lynn & Lieberson LLC raised its stake in PerkinElmer by 1.3% in the second quarter. Moody Lynn & Lieberson LLC now owns 7,618 shares of the company’s stock valued at $399,000 after buying an additional 99 shares during the period. Toth Financial Advisory Corp raised its stake in PerkinElmer by 2.0% in the second quarter. Toth Financial Advisory Corp now owns 10,100 shares of the company’s stock valued at $529,000 after buying an additional 200 shares during the period. Finally, Sit Investment Associates Inc. raised its stake in PerkinElmer by 1.5% in the second quarter. Sit Investment Associates Inc. now owns 14,925 shares of the company’s stock valued at $782,000 after buying an additional 225 shares during the period. Hedge funds and other institutional investors own 90.32% of the company’s stock.

Shares of PerkinElmer Inc. (NYSE:PKI) opened at 51.71 on Monday. PerkinElmer Inc. has a one year low of $39.50 and a one year high of $57.28. The company has a market capitalization of $5.66 billion, a PE ratio of 24.71 and a beta of 0.85. The company’s 50-day moving average is $54.26 and its 200-day moving average is $53.56.

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 10th. Investors of record on Friday, October 14th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.54%. The ex-dividend date of this dividend is Wednesday, October 12th. PerkinElmer’s dividend payout ratio is currently 13.33%.

Several equities research analysts recently weighed in on the stock. JPMorgan Chase & Co. increased their price objective on shares of PerkinElmer from $52.00 to $55.00 and gave the stock a “neutral” rating in a research note on Friday, August 5th. Barclays PLC upped their target price on shares of PerkinElmer from $50.00 to $52.00 and gave the stock an “underweight” rating in a research report on Friday, August 5th. BTIG Research restated a “hold” rating on shares of PerkinElmer in a research report on Friday, August 5th. Mizuho cut shares of PerkinElmer from a “buy” rating to a “neutral” rating and set a $56.00 target price for the company. in a research report on Friday, August 5th. Finally, Jefferies Group upped their target price on shares of PerkinElmer from $52.00 to $55.00 and gave the stock a “hold” rating in a research report on Friday, August 5th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $54.93.

In other PerkinElmer news, Director Kenton J. Sicchitano sold 15,189 shares of the business’s stock in a transaction dated Wednesday, August 24th. The shares were sold at an average price of $54.87, for a total value of $833,420.43. Following the completion of the transaction, the director now directly owns 43,160 shares of the company’s stock, valued at $2,368,189.20. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Patrick J. Sullivan sold 8,308 shares of the business’s stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $54.74, for a total transaction of $454,779.92. Following the completion of the transaction, the director now directly owns 41,829 shares of the company’s stock, valued at $2,289,719.46. The disclosure for this sale can be found here. Corporate insiders own 2.30% of the company’s stock.

PerkinElmer Company Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental and laboratory markets. The Company’s operating segments include Human Health, Environmental Health and Corporate. The Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier.

Related posts

Leave a Comment